US 12338437
OPA1 antisense oligomers for treatment of conditions and diseases
granted A61KA61K31/7088A61K31/7125
Quick answer
US patent 12338437 (OPA1 antisense oligomers for treatment of conditions and diseases) held by STOKE THERAPEUTICS, INC. expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- STOKE THERAPEUTICS, INC.
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7088, A61K31/7125, A61K45/06, A61K9/0048